デジタル糖尿病管理市場レポート：動向、予測、競合分析 (2031年まで)

世界のデジタル糖尿病管理市場の将来は、病院、在宅環境、診断センター市場における機会で有望視されています。世界のデジタル糖尿病管理市場は、2025年から2031年までのCAGRが10.8%で、2031年までに推定344億米ドルに達すると予測されます。この市場の主な促進要因は、糖尿病の有病率の増加、技術の進歩、糖尿病管理のためのクラウドベースの企業向けソリューションの採用拡大です。

• Lucintelの予測では、糖尿病管理向けインスリン自己投与のためのスマートインスリンポンやとインスリンパッチの採用が拡大しているため、種類別ではウェアラブルデバイスが予測期間中も大きなセグメントであり続けます。
• 最終用途別では、遠隔患者モニタリングのためのデジタル技術の採用が増加し、病院内で高度なデジタル糖尿病管理ツールが容易に利用できることから、病院が引き続き最大セグメントとなります。
• 地域別では、接続型糖尿病管理デバイスの需要増加、糖尿病管理・肥満アプリの採用急増、同地域における自己糖尿病管理意識の高まりにより、北米が予測期間中に最も高い成長を遂げると予想されます。

デジタル糖尿病管理市場の戦略的成長機会

技術主導の進歩と消費者行動の変容が、デジタル糖尿病管理市場の成長機会を生み出しています。開発の重点分野が明らかになりつつあり、主要な用途は潜在的に変革をもたらす可能性があります。本稿では、検討すべき5つの戦略オプションを紹介します。

• 遠隔医療と遠隔モニタリングソリューションの拡大：成長の機会は、遠隔医療と遠隔モニタリング・ソリューションの拡大にあります。これらの機器によって、医師はバーチャルな訪問を行うことができ、それによって患者のヘルスケアサービスへのアクセスが増加します。遠隔糖尿病管理をサポートし、患者の関与を強化するデジタルツールの受け入れ拡大は、より多くの遠隔医療が利用されるにつれて観察されます。
• ウェアラブル技術の革新：先進的な持続血糖モニター（CGM）やスマートインスリンペンは、ウェアラブル技術の大きな進歩であり、新たな成長機会をもたらします。ウェアラブルデバイスと連携するモバイルアプリケーションは、糖尿病治療の成果を改善する可能性を秘めています。将来のウェアラブル機器には、機能強化や精度向上が含まれる可能性があり、その結果、患者と医療提供者にとってより良い治療結果がもたらされます。
• 個別化された糖尿病管理システム：糖尿病治療のためのAIベースのパーソナライズドシステムの開発は、現実的な可能性です。このようなソリューションは、個々の情報に基づいて的確な提案を行い、より良い疾病管理につなげることができます。特定の患者の問題に対処することで、企業は全体的な管理と健康アウトカムを向上させることができます。
• デジタル糖尿病教育プログラムの成長：これはデジタル糖尿病教育プログラムにとって大きな成長機会となります。これらのプログラムは、患者により良い病状管理を行うために必要な貴重な情報、リソース、サポートを提供することができます。インタラクティブで魅力的なコンテンツを取り入れることで、デジタル教育プログラムにおける患者の知識を高め、糖尿病治療の改善につなげることができます。

デジタル糖尿病管理市場における戦略的成長機会は、統合の強化、遠隔診療の拡大、個別化ソリューションのための技術活用に重点が置かれています。統合プラットフォームの開発、ウェアラブル技術の進歩、デジタル教育への投資は、糖尿病管理の大幅な改善につながる可能性があります。アクセスしやすくパーソナライズされた、より効果的なケアの提供は、患者とヘルスケアプロバイダーの双方に利益をもたらすと同時に、この市場を再形成することができます。

デジタル糖尿病管理市場の促進要因・課題

デジタル糖尿病管理市場の成長は、その進展に影響を与える様々な要因と課題によって左右されます。市場情勢は、技術的進歩、経済的要因、規制状況によって形成されます。そこで本稿では、市場に影響を与える主な促進要因・課題の分析を紹介します。

デジタル糖尿病管理市場の促進要因は以下の通りです：

• 技術の進歩：デジタル糖尿病管理市場は、改良されたCGM、AI分析、ウェアラブルデバイスなど、さまざまな技術的進歩によって牽引されています。これらの開発により、グルコースモニタリング、データ精度、個別ケアが向上し、患者の転帰改善につながります。
• 遠隔医療の採用増加：遠隔医療サービスの普及により、糖尿病治療へのアクセスが拡大しています。遠隔診察やモニタリングのオプションにより、患者はタイムリーな支援を受けやすくなり、全体的なコントロールとアドヒアランスが向上しています。
• 患者参加への注目の高まり：患者の自己管理を促し、エンゲージメントを向上させるデジタルプラットフォームへの注目が高まっています。インタラクティブなアプリケーションやオンラインコーチングプログラムは、患者の糖尿病治療への積極的な参加を促し、その結果、処方された治療レジメンの遵守率が向上します。

デジタル糖尿病管理市場における課題は以下の通りです：

• データのプライバシーとセキュリティに関する懸念：デジタル糖尿病管理における重要な課題は、患者データのプライバシーとセキュリティの保護です。より多くの健康情報が収集されるにつれ、データ漏洩や不正アクセスに対する懸念が生じ、患者の信頼や導入に影響を及ぼす可能性があります。
• 規制上のハードル：新たなデジタルヘルス・テクノロジーに対する規制要件や承認の取得は困難です。規制上の障壁は、革新的ソリューションのイントロダクションを遅らせ、市場の成長を妨げる可能性があります。
• 統合と相互運用性の問題：新しいデジタルツールを既存の医療システムに統合し、データの相互運用性を確保する際に課題が生じます。標準化の欠如と互換性の問題は、デジタル糖尿病ケアソリューションの円滑な利用を妨げる可能性があります。

デジタル糖尿病管理市場の成長は、いくつかの課題とともにさまざまな促進要因によって形作られています。技術進歩、遠隔医療サービスの採用拡大、患者エンゲージメントの重視が主な促進要因である一方、データプライバシーに関する懸念、規制上のハードル、統合のジレンマが大きな課題となっています。デジタル糖尿病管理の進歩を促進し、糖尿病患者のケアを改善するためには、これらのボトルネックを克服し、これらの促進要因によってもたらされる機会を活用しなければなりません。

目次

第1章 エグゼクティブサマリー

第2章 世界のデジタル糖尿病管理市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のデジタル糖尿病管理市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のデジタル糖尿病管理市場：製品別
  • スマート血糖メーター
  • 持続血糖モニタリングシステム
  • スマートインスリンペン
  • スマートインスリンポンプ
  • アプリ
• 世界のデジタル糖尿病管理市場：種類別
  • ウェアラブルデバイス
  • ハンドヘルドデバイス
• 世界のデジタル糖尿病管理市場：最終用途別
  • 病院
  • 在宅医療
  • 診断センター

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のデジタル糖尿病管理市場：地域別
• 北米のデジタル糖尿病管理市場
• 欧州のデジタル糖尿病管理市場
• アジア太平洋のデジタル糖尿病管理市場
• その他地域のデジタル糖尿病管理市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のデジタル糖尿病管理市場の成長機会：製品別
  • 世界のデジタル糖尿病管理市場の成長機会：種類別
  • 世界のデジタル糖尿病管理市場の成長機会：最終用途別
  • 世界のデジタル糖尿病管理市場の成長機会：地域別
• 世界のデジタル糖尿病管理市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のデジタル糖尿病管理市場の生産能力拡大
  • 世界のデジタル糖尿病管理市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $34.4 billion by 2031 with a CAGR of 10.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of diabetes, technological advancements, and the growing adoption of cloud-based enterprise solutions for diabetes management.

• Lucintel forecasts that, within the type category, wearable devices will remain the larger segment over the forecast period due to the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.
• Within the end use category, hospitals will remain the largest segment due to the increasing adoption of digital technologies for remote patient monitoring and the easy availability of advanced digital diabetes management tools in hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the increasing demand for connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness of self-diabetes management in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Digital Diabetes Management Market

The digital diabetes management market is evolving rapidly through various directions that will shape its future. Numerous innovative solutions and advanced technology integration have led to personalized and efficient approaches to managing diabetes.

• Artificial Intelligence Integration: Digital diabetes management tools are increasingly adopting artificial intelligence (AI). AI algorithms use data from continuous glucose monitors (CGMs) and other sources to offer personalized insights and recommendations. This development enhances prediction, allowing users to make better decisions regarding their diabetes management practices. AI-based tools are improving glucose prediction accuracy, thus enhancing overall disease control and patient outcomes.
• Growth of Wearable Technology: In digital diabetes management, wearable technology is becoming very popular, with examples including smart insulin pens and advanced CGMs. These wearables can monitor glucose levels in real time and deliver insulin automatically, thereby improving convenience and accuracy in managing diabetes. It is now simpler for individuals to monitor their sugar levels with the help of wearable technology, resulting in better patient involvement and improved health outcomes.
• Expansion of Telehealth Services: Diabetes care is being revolutionized by the expansion of telehealth services, which offer remote consultations and support. With digital platforms, patients can connect with healthcare providers without necessarily appearing in their offices, making the management of diabetes mellitus more accessible and convenient. This especially benefits those in remote or underserved areas, who now have better access to specialized care and improved overall diabetes management.
• Enhanced Data Interoperability: This trend is growing because it allows for seamless integration of diabetes management tools into electronic health records (EHRs) and other healthcare systems. It enables better coordination between patients and practitioners, facilitating more comprehensive and efficient care. Sharing enhanced data ensures that all members of the medical team always have the latest patient information, leading to better-informed decisions about treatment that result in improved patient outcomes.

The marketplace has been remodeled by these novel trends within digital diabetes care systems that embrace new technology and inventive solutions, thus improving patient welfare. Diabetes management is being drastically enhanced due to AI integration, wearable technology, telehealth services, data interoperability, and a focus on patient engagement. These trends aim to foster personalized accessibility and efficacy in managing diabetes, thereby significantly improving the health status of diabetes patients and changing the landscape of diabetes treatment.

Recent Developments in the Digital Diabetes Management Market

Recent developments in digital diabetes management have revolutionized diabetes monitoring and treatment. The application of advanced technologies such as wearable devices, mobile apps, and data analytics has led to better patient care and disease control. These improvements have enhanced real-time monitoring capabilities, personalized treatment plans, and increased overall patient involvement.

• Integration of Continuous Glucose Monitoring (CGM) Systems: The integration of continuous glucose monitoring (CGM) systems with mobile applications represents a significant advancement. CGMs provide real-time blood sugar readings that are sent to mobile apps for tracking purposes. With this development, patients can regularly check their blood sugar levels, enabling them to maintain better glycemic control and make more informed decisions about their care regimens. Seamless data sharing between CGMs and apps improves patient engagement and supports early interventions in diabetes.
• Dynamic Progress in Artificial Intelligence (AI) through Diabetic Care: Glucose data is analyzed and trends are predicted using artificial intelligence (AI). AI algorithms analyze CGM data and other sources to generate personalized suggestions or alerts. This technology enables better insulin dosing and more effective diabetes management by predicting glucose fluctuations before they occur. The overall treatment outcomes from AI in predicting and managing diabetes are improving, leading to more individualized care.
• Expansion of Telehealth Services: The expansion of telehealth services has changed how diabetes is managed by providing remote consultations and support. Patients can now consult medical practitioners without having to travel long distances, especially those who live in rural areas with limited access to health services. Telehealth platforms ensure continuous monitoring and timely check-ins, ensuring that patients receive the right support when it is most needed. This development improves accessibility and convenience for individuals managing diabetes.
• Increased Focus on Patient Engagement Platforms: Patient engagement platforms are becoming increasingly popular. Consequently, diabetes patients are being educated and empowered through interactive apps and digital coaching programs. These platforms have features that help monitor progress, set goals, and motivate users. As a result, patients are now adhering to treatment regimens, thereby enhancing their overall health.

The digital diabetes management market has recently undergone numerous changes that have made it more accurate and patient-friendly. Diabetes is monitored and managed differently today through combined glucose monitoring devices, AI-powered analytics, remote healthcare services, patient engagement systems, and smart insulin pens. Consequently, diabetic patients now have improved access to care, including real-time data provision, personalized recommendations, and better outcomes.

Strategic Growth Opportunities for Digital Diabetes Management Market

Technology-driven advancements and transforming consumer behavior have created opportunities for growth in the digital diabetes management market. Focused areas for development are becoming apparent, with key applications offering a potentially transformative experience. This article presents five strategic options to consider.

• Expansion of Telemedicine and Remote Monitoring Solutions: The opportunity for growth lies in expanding telehealth and remote monitoring solutions. These devices enable physicians to conduct virtual visits, thereby increasing access to healthcare services for patients. The increased acceptance of digital tools that support remote diabetes management and enhance patient involvement can be observed as more distance care is utilized.
• Innovation in Wearable Technology: Advanced continuous glucose monitors (CGMs) and smart insulin pens represent significant advancements in wearable technology that present new growth opportunities. Mobile applications that connect with wearable devices have the potential to improve diabetes treatment outcomes. Future wearables could include enhanced functionalities and increased accuracy, resulting in better outcomes for patients and providers.
• Personalized Diabetes Management Systems: Developing AI-based personalized systems for diabetes care is a viable possibility. Such solutions can offer accurate suggestions based on individual information, leading to better disease control. By addressing specific patient issues, companies can enhance overall management and health outcomes.
• Growth of Digital Diabetes Education Programs: This presents a significant growth opportunity for digital diabetes education programs. These programs can provide patients with valuable information, resources, and support necessary for better managing their condition. By incorporating interactive and engaging content, patient knowledge in digital education programs can be enhanced, leading to improved diabetes care.

Strategic growth opportunities in the digital diabetes management market focus on enhancing integration, expanding remote care, and leveraging technology for personalized solutions. The development of integrated platforms, advancements in wearable technology, and investments in digital education could lead to substantial improvements in diabetes management. More effective care offerings that are accessible and personalized can reshape this market while benefiting both patients and healthcare providers.

Digital Diabetes Management Market Driver and Challenges

The growth of the digital diabetes management market is influenced by various factors and challenges that impact its progress. The market landscape is shaped by technological advancements, economic factors, and regulatory considerations. Thus, this paper presents an analysis of major drivers and challenges affecting the market.

The factors driving the digital diabetes management market include:

• Technological Advancements: The digital diabetes management market is being driven by a range of technological advancements, including improved CGMs, AI analytics, and wearable devices. These developments boost glucose monitoring, data precision, and individualized care, thereby leading to better patient outcomes.
• Increased Adoption of Telehealth: The increasing uptake of telehealth services is widening access to diabetes treatment. Remote consultation and monitoring options are making it easier for patients to receive timely assistance, enhancing overall control and adherence.
• Growing Focus on Patient Engagement: There is an increasing focus on digital platforms that encourage patient self-management and improve engagement. Interactive applications and online coaching programs help individuals participate more actively in their diabetes care, resulting in greater compliance with prescribed treatment regimens.

Challenges in the digital diabetes management market include:

• Data Privacy and Security Concerns: A significant challenge in digital diabetes management is protecting the privacy and security of patient data. As more health information is collected, there are concerns about data breaches and unauthorized access, which can impact patient trust and adoption.
• Regulatory Hurdles: Navigating regulatory requirements and obtaining approvals for new digital health technologies can be difficult. Regulatory barriers may delay the introduction of innovative solutions and hinder market growth.
• Integration and Interoperability Issues: Challenges arise when integrating new digital tools into existing healthcare systems and ensuring data interoperability. Lack of standardization and compatibility issues may prevent the smooth use of digital diabetes care solutions.

Various drivers shape the growth of the digital diabetes management market, along with several challenges. Technological advancements, increased adoption of telehealth services, and a focus on patient engagement are its main drivers, while concerns over data privacy, regulatory hurdles, and integration dilemmas pose significant challenges. To foster progress in digital diabetes management and improve care for diabetic patients, we must overcome these bottlenecks and capitalize on the opportunities presented by these drivers.

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management market by product, type, end use, and region

Digital Diabetes Management Market by Product [Analysis by Value from 2019 to 2031]:

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps

Digital Diabetes Management Market by Type [Analysis by Value from 2019 to 2031]:

• Wearable Devices
• Handheld Devices

Digital Diabetes Management Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Home settings
• Diagnostic Centers

Digital Diabetes Management Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Digital Diabetes Management Market

Digital diabetes management has been experiencing significant recent advancements that have greatly influenced the approach to diabetes care globally. Patient monitoring, engagement, and treatment personalization are being enhanced by advanced technological integrations such as wearable devices, mobile apps, and artificial intelligence (AI). These innovations address the increasing need for efficient and user-friendly solutions for diabetes management, offering real-time data and insights to improve patient outcomes.

• United States: In the United States, there has been noticeable uptake of high-tech digital diabetes management platforms. For example, continuous glucose monitors (CGMs) can now be integrated with smartphone applications, enabling real-time glucose tracking and management. Moreover, analytics based on AI are improving predictive capabilities, facilitating personalized therapies. Teleservices, such as telehealth and digital diabetes coaching, have also grown, reinforcing proper disease control and improving patient relationships while increasing access to care.
• China: The expansion of mobile health (mHealth) applications and telemedicine is driving rapid growth in digital diabetes management in China. Local tech companies are designing sophisticated platforms that merge CGM data with health management apps, providing users with comprehensive diabetes control tools. Government initiatives have been implemented to promote the integration of digital health solutions into mainstream care delivery systems, enhancing access and encouraging widespread utilization of diabetes management technologies in urban and rural areas.
• Germany: Smart insulin pens and advanced CGMs have revolutionized digital diabetes management in Germany. The use of these devices has improved glucose monitoring accuracy and insulin delivery. Moreover, Germany emphasizes data interoperability to enable easy integration between EHRs and diabetes management tools. Consequently, this connection enhances coordination between medical practitioners and their clients, leading to better treatment outcomes for both patients who comply with prescribed medications and the physicians themselves.
• India: India has seen the expansion of digital diabetes management through affordable mobile applications and wearable technologies. To address the high prevalence of diabetes in India, these tools provide simple-to-use glucose monitoring and management solutions. In particular, the growth of telemedicine platforms is facilitating access to diabetes care in underserved and remote areas. Efforts are underway to boost digital literacy and integrate these innovations into conventional healthcare delivery systems.
• Japan: Through highly accurate CGMs and automated insulin delivery systems, Japan is advancing in digital diabetes management. The goal is to integrate these systems with national health databases to improve patient tracking and intervention efficiency. Moreover, Japan is exploring AI-driven predictive analytics and personalized diabetes interventions that will enhance clinical performance among patients and streamline healthcare services. Furthermore, more patient education avenues, such as online platforms, are now available for individuals managing this disease.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Digital Diabetes Management Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Digital Diabetes Management Market by Product
  • 3.3.1: Smart Glucose Meter
  • 3.3.2: Continuous Blood Glucose Monitoring System
  • 3.3.3: Smart Insulin Pens
  • 3.3.4: Smart Insulin Pumps
  • 3.3.5: Apps
• 3.4: Global Digital Diabetes Management Market by Type
  • 3.4.1: Wearable Devices
  • 3.4.2: Handheld Devices
• 3.5: Global Digital Diabetes Management Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Home settings
  • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Digital Diabetes Management Market by Region
• 4.2: North American Digital Diabetes Management Market
  • 4.2.1: North American Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.3: European Digital Diabetes Management Market
  • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.4: APAC Digital Diabetes Management Market
  • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.5: ROW Digital Diabetes Management Market
  • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
  • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
  • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
  • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
• 6.2: Emerging Trends in the Global Digital Diabetes Management Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Medtronic
• 7.3: F. Hoffmann-La Roche
• 7.4: Bayer
• 7.5: Lifescan
• 7.6: Dexcom
• 7.7: Sanofi
• 7.8: Insulet Corporation
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: B Braun Melsungen